Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical Cord-derived Mesenchymal Stem Cell for BPD
NCT03645525Phase 2Withdrawn
- Sponsor
- Children's Hospital of Fudan University
- Start
- Dec 2019
- Primary completion
- Oct 2022
- Countries
- 1
01
Overview
Phase 2, randomised trial in bronchopulmonary dysplasia (BPD) (2 arms), sponsored by Children's Hospital of Fudan University. Primary endpoint: Oxygen requirement 3 days after transplantation. Planned start Dec 2019; status: withdrawn.
02
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NCT03645525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03645525.